LIFESTANCE UPDATE


Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LifeStance To Contact Him Directly To Discuss Their Options

 

NEW YORK, NY - (NewMediaWire) - September 24, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST).

 

If you suffered losses exceeding $50,000 investing in LifeStance stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/LFST.

 

A person in a suit  Description automatically generated with medium confidence

 

There is no cost or obligation to you. 

 

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.


On Wednesday, August 11, 2021, LifeStance released its second quarter ended June 30, 2021, financial results, reporting a net loss of $70 million. Just two months ago, on or about June 10, 2021, LifeStance sold about 40 million shares of stock in its initial public stock offering (the "IPO") at $18 a share, raising nearly $720 million in new capital.


Since the IPO, the stock has plummeted; in early morning trading on August 12, 2021, the stock was trading as low as $10.72.


Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.